Safety and Acceptability Study of PrePex Device When Removing the Foreskin Shortly After Placement of Device
NCT ID: NCT03132285
Last Updated: 2017-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
500 participants
INTERVENTIONAL
2017-03-11
2017-06-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Acceptability of the PrePex™ Device for Male Circumcision in Zambia
NCT01844102
Safety and Efficacy of the PrePex Device Circumcision When Performed by Nurses
NCT01956383
Evaluation of the PrePex Device for Rapid Scale-up of VMMC, Phase 3 Field Implementation Trial With HIV + Adult Males
NCT03218839
Evaluation of Safety and Efficacy of the PrePexTM Device for Rapid Scale up of Adult MC Programs in Zimbabwe
NCT01956396
Safety and Efficacy Study of Non-Surgical MC Device for Adolescent Male Population Including Contraindicated Subjects
NCT02581722
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Five hundred (500) males scheduled for voluntary circumcision performed by clinicians or nurses using the PrePex.
Theses clinicians and nurses have already been trained in the Prepex procedure and will undergo further training in the modification to the technique. Study duration per participant will be up to 8 weeks and will include three follow up visits and one phone call follow up.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PrePex Day 0 foreskin removal
Day 0 foreskin removal
PrePex
Prepex is a non surgical male circumcision device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PrePex
Prepex is a non surgical male circumcision device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Uncircumcised
* Participant wants to be circumcised
* Participant assent to the procedure
* Legal guardian consent to the procedure for ages 13-18 years
* Able to understand the study procedures and requirements
* Agrees to abstain from sexual intercourse for 8 weeks after circumcision
* Agrees to abstain from masturbation for at least 2 weeks after Removal
* Agrees to return to the health care facility for follow-up visits (or as instructed) after his circumcision for a period of 7 weeks post removal (8 weeks total)
* Participant able to comprehend and freely give informed consent for participation in this study and is considered by the investigator to have good compliance for the study
Exclusion Criteria
* Active genital infection, anatomic abnormality or other condition, which in the opinion of the investigator prevents the participant from undergoing a circumcision
* Participant with the following diseases/conditions: phimosis, paraphimosis, adhesions, warts under the prepuce, torn or tight frenulum, narrow prepuce, hypospadias, epispadias
* Known bleeding / coagulation abnormality, uncontrolled diabetes
* Participant that to the opinion of the investigator is not a good candidate
* Diabetes Mellitus
* HIV Sero-positive
13 Years
49 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, Zambia
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Linyama
General surgeon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Matero Main Clinic
Lusaka, Lusaka Province, Zambia
Dambwa North Clinic
Livingstone, , Zambia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.